Published in J Photochem Photobiol B on July 01, 1996
Guiding neuronal development with in situ microfabrication. Proc Natl Acad Sci U S A (2004) 1.13
Multiphoton fabrication of chemically responsive protein hydrogels for microactuation. Proc Natl Acad Sci U S A (2008) 0.95
Oxidative modification of cytochrome c by singlet oxygen. Free Radic Biol Med (2008) 0.92
Induction of Covalently Crosslinked p62 Oligomers with Reduced Binding to Polyubiquitinated Proteins by the Autophagy Inhibitor Verteporfin. PLoS One (2014) 0.85
Discovery and characterization of a photo-oxidative histidine-histidine cross-link in IgG1 antibody utilizing ¹⁸O-labeling and mass spectrometry. Anal Chem (2014) 0.83
Tyrosine/cysteine cluster sensitizing human γD-crystallin to ultraviolet radiation-induced photoaggregation in vitro. Biochemistry (2014) 0.77
Decreased metastatic phenotype in cells resistant to aminolevulinic acid-photodynamic therapy. Cancer Lett (2008) 0.75
Phthalocyanines as photosensitizers in biological systems and for the photodynamic therapy of tumors. Photochem Photobiol (1986) 1.80
Hybrid hydrogels assembled from synthetic polymers and coiled-coil protein domains. Nature (1999) 1.78
The Mechanical Properties of Rat Tail Tendon. J Gen Physiol (1959) 1.65
Effect of molecular weight (Mw) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats. J Biomed Mater Res (1987) 1.60
The Mechanism of the Photochemical Activity of Isolated Chloroplasts. III. Dependence of Velocity on Light Intensity. Plant Physiol (1959) 1.59
Studies on the mechanism of bacteria photosensitization by meso-substituted cationic porphyrins. J Photochem Photobiol B (1996) 1.50
Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate. J Control Release (1998) 1.45
Efficacy of the chemotherapeutic action of HPMA copolymer-bound doxorubicin in a solid tumor model of ovarian carcinoma. Int J Cancer (2000) 1.34
HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line. J Control Release (1998) 1.33
Biodistribution and antitumour efficacy of long-circulating N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugates in nude mice. Eur J Cancer (2001) 1.30
Soluble biomedical polymers. Polim Med (1977) 1.28
Protein-resistant surfaces prepared by PEO-containing block copolymer surfactants. J Biomed Mater Res (1989) 1.24
Chronic exposure to HPMA copolymer-bound adriamycin does not induce multidrug resistance in a human ovarian carcinoma cell line. J Control Release (1999) 1.12
Porphyrins and related compounds as photodynamic sensitizers. Ann N Y Acad Sci (1975) 1.08
Surface properties of copolymers of alkyl methacrylates with methoxy (polyethylene oxide) methacrylates and their application as protein-resistant coatings. Biomaterials (1990) 1.07
Fate of N-(2-hydroxypropyl)methacrylamide copolymers with pendent galactosamine residues after intravenous administration to rats. Biochim Biophys Acta (1986) 1.04
Tyrosinamide residues enhance pinocytic capture of N-(2-hydroxypropyl)methacrylamide copolymers. Biochim Biophys Acta (1984) 1.03
Novel pH-sensitive hydrogels with adjustable swelling kinetics. Biomaterials (1998) 1.00
Hybrid hydrogels cross-linked by genetically engineered coiled-coil block proteins. Biomacromolecules (2001) 1.00
Comparison of the anticancer effect of free and HPMA copolymer-bound adriamycin in human ovarian carcinoma cells. Pharm Res (1999) 0.99
Long-term experience with poly(glycol monomethacrylate) gel in plastic operations of the nose. J Biomed Mater Res (1975) 0.98
The pharmacokinetics of polymer-bound adriamycin. Biochem Pharmacol (1990) 0.98
Controlled biodegradability of polymers--a key to drug delivery systems. Biomaterials (1984) 0.97
Polymerizable Fab' antibody fragments for targeting of anticancer drugs. Nat Biotechnol (1999) 0.97
Feasibility of using a bone-targeted, macromolecular delivery system coupled with prostaglandin E(1) to promote bone formation in aged, estrogen-deficient rats. Pharm Res (2008) 0.95
Enhanced biorecognition and internalization of HPMA copolymers containing multiple or multivalent carbohydrate side-chains by human hepatocarcinoma cells. Bioconjug Chem (2001) 0.95
Design of a multivalent galactoside ligand for selective targeting of HPMA copolymer-doxorubicin conjugates to human colon cancer cells. Eur J Cancer (2004) 0.94
HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 1. influence of the method of synthesis on the binding affinity to OVCAR-3 ovarian carcinoma cells in vitro. J Drug Target (1996) 0.94
Antitumor activity of N-(2-hydroxypropyl) methacrylamide copolymer-Mesochlorine e6 and adriamycin conjugates in combination treatments. Clin Cancer Res (2000) 0.93
Activity of N-(2-hydroxypropyl)methacrylamide copolymers containing daunomycin against a rat tumour model. Biochem Pharmacol (1989) 0.93
The effects of porphyrin structure and aggregation state on photosensitized processes in aqueous and micellar media. Photochem Photobiol (1986) 0.93
Preliminary evaluation of caspases-dependent apoptosis signaling pathways of free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells. J Control Release (2001) 0.93
Combination chemotherapy and photodynamic therapy of targetable N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin/mesochlorin e(6)-OV-TL 16 antibody immunoconjugates. J Control Release (2001) 0.93
Photodynamic crosslinking of proteins. II. Photocrosslinking of a model protein-ribonuclease A. J Photochem Photobiol B (1996) 0.92
HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. II. Processing in epithelial ovarian carcinoma cells in vitro. Int J Cancer (1998) 0.92
High-molecular weight HPMA copolymer-adriamycin conjugates. J Control Release (1999) 0.91
Biodistribution of free and N-(2-hydroxypropyl)methacrylamide copolymer-bound mesochlorin e(6) and adriamycin in nude mice bearing human ovarian carcinoma OVCAR-3 xenografts. J Control Release (1999) 0.91
Polymers containing enzymatically degradable bonds. VI. Hydrophilic gels cleavable by chymotrypsin. Biomaterials (1982) 0.91
Pinocytic uptake and intracellular degradation of N-(2-hydroxypropyl)methacrylamide copolymers. A potential drug delivery system. Biochim Biophys Acta (1981) 0.91
Polymers containing enzymatically degradable bonds V. Hydrophilic polymers degradable by papain. Biomaterials (1980) 0.91
A polymeric drug delivery system for the simultaneous delivery of drugs activatable by enzymes and/or light. J Biomater Sci Polym Ed (1994) 0.91
Photodynamic crosslinking of proteins. III. Kinetics of the FMN- and rose bengal-sensitized photooxidation and intermolecular crosslinking of model tyrosine-containing N-(2-hydroxypropyl)methacrylamide copolymers. Photochem Photobiol (1999) 0.90
Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro. Br J Cancer (1987) 0.90
Stability in rat plasma and serum of lysosomally degradable oligopeptide sequences in N-(2-hydroxypropyl) methacrylamide copolymers. Biomaterials (1985) 0.90
Combination chemotherapy and photodynamic therapy with N-(2-hydroxypropyl) methacrylamide copolymer-bound anticancer drugs inhibit human ovarian carcinoma heterotransplanted in nude mice. Cancer Res (1996) 0.90
Hydrogels for site-specific drug delivery to the colon: in vitro and in vivo degradation. Pharm Res (1992) 0.89
Targeting of N-(2-hydroxypropyl)methacrylamide copolymers to liver by incorporation of galactose residues. Biochim Biophys Acta (1983) 0.89
International conference on singlet oxygen and related species in chemistry and biology: review and general discussion. Photochem Photobiol (1979) 0.88
The influence of cytotoxicity of macromolecules and of VEGF gene modulated vascular permeability on the enhanced permeability and retention effect in resistant solid tumors. Pharm Res (2000) 0.88
Prolonged blood circulation in rats of nanospheres surface-modified with semitelechelic poly[N-(2-hydroxypropyl)methacrylamide]. Pharm Res (1995) 0.88
Zinc tetrasulphophthalocyanine as a photodynamic sensitizer for biomolecules. Int J Radiat Biol Relat Stud Phys Chem Med (1986) 0.87
Enantioselective release of 5-fluorouracil from N-(2-hydroxypropyl)methacrylamide-based copolymers via lysosomal enzymes. Bioconjug Chem (1995) 0.87
Liberation of doxorubicin from HPMA copolymer conjugate is essential for the induction of cell cycle arrest and nuclear fragmentation in ovarian carcinoma cells. J Control Release (2007) 0.87
Time- and concentration-dependent apoptosis and necrosis induced by free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells. J Control Release (2000) 0.86
Biorecognizable HPMA copolymer-drug conjugates for colon-specific delivery of 9-aminocamptothecin. J Control Release (2001) 0.86
Chronic exposure of human ovarian carcinoma cells to free or HPMA copolymer-bound mesochlorin e6 does not induce P-glycoprotein-mediated multidrug resistance. Biomaterials (2000) 0.85
Phagocytosis of human blood leukocytes: a simple micromethod. Immunol Lett (1982) 0.85
Antibody-directed affinity therapy applied to the immune system: in vivo effectiveness and limited toxicity of daunomycin conjugated to HPMA copolymers and targeting antibody. Clin Immunol Immunopathol (1988) 0.85
Photothermal sensitizers: possible use in tumor therapy. J Photochem Photobiol B (1990) 0.84
Controlled release of drug model from N-(2-hydroxypropyl)-methacrylamide copolymers. Ann N Y Acad Sci (1985) 0.84
The effect of chemical structure on the photosensitizing efficiencies of porphyrins. Photochem Photobiol (1977) 0.83
Lysosomal degradability of poly(alpha-amino acids). J Biomed Mater Res (1997) 0.83
Biorecognition of HPMA copolymer-lectin conjugates as an indicator of differentiation of cell-surface glycoproteins in development, maturation, and diseases of human and rodent gastrointestinal tissues. J Biomed Mater Res (2000) 0.83
Effect of the chemical structure of N-(2-hydroxypropyl)methacrylamide copolymers on their ability to induce antibody formation in inbred strains of mice. Biomaterials (1984) 0.83
Synthesis of bioadhesive lectin-HPMA copolymer-cyclosporin conjugates. Bioconjug Chem (2000) 0.83
Immunogenicity of N-(2-hydroxypropyl)-methacrylamide copolymers--potential hapten or drug carriers. Folia Microbiol (Praha) (1983) 0.83
Responsive hybrid hydrogels with volume transitions modulated by a titin immunoglobulin module. Bioconjug Chem (2000) 0.83
Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia. Br J Cancer (1988) 0.83
The influence of a colonic microbiota on HPMA copolymer lectin conjugates binding in rodent intestine. J Drug Target (2001) 0.83
Self-assembled peptides exposing epitopes recognizable by human lymphoma cells. Bioconjug Chem (2000) 0.83
New types of synthetic infusion solutions. III. Elimination and retention of poly-[N-(2-hydroxypropyl)methacrylamide] in a test organism. J Biomed Mater Res (1976) 0.83
The coiled coils in the design of protein-based constructs: hybrid hydrogels and epitope displays. J Control Release (2001) 0.83
Synthesis of starlike N-(2-hydroxypropyl)methacrylamide copolymers: potential drug carriers. Biomacromolecules (2000) 0.83
Degradation of side-chains of N-(2-hydroxypropyl)methacrylamide copolymers by lysosomal thiol-proteinases. Biosci Rep (1982) 0.82
Cooperativity between free and N-(2-hydroxypropyl) methacrylamide copolymer bound adriamycin and meso-chlorin e6 monoethylene diamine induced photodynamic therapy in human epithelial ovarian carcinoma in vitro. Int J Oncol (1999) 0.82
Effect of galactose on interaction of N-(2-hydroxypropyl)methacrylamide copolymers with hepatoma cells in culture: preliminary application to an anticancer agent, daunomycin. Hepatology (1989) 0.82
The cytoplasmic escape and nuclear accumulation of endocytosed and microinjected HPMA copolymers and a basic kinetic study in Hep G2 cells. AAPS PharmSci (2001) 0.82
Synthesis and characterization of HPMA copolymer-aminopropylgeldanamycin conjugates. J Control Release (2001) 0.82
Potential of lectin-N-(2-hydroxypropyl)methacrylamide copolymer-drug conjugates for the treatment of pre-cancerous conditions. J Control Release (2001) 0.81
Macrophages of athymic nude mice: Fc receptors, C receptors, phagocytic and pinocytic activities. Eur J Cell Biol (1984) 0.81
Modification of cyclosporin A and conjugation of its derivative to HPMA copolymers. Bioconjug Chem (2001) 0.81
Functionalized semitelechelic poly[N-(2-hydroxypropyl)methacrylamide] for protein modification. Bioconjug Chem (1999) 0.81
Enhanced antitumor activity of combinations of free and HPMA copolymer-bound drugs. Int J Pharm (2007) 0.81
Effect of porosity of heterogeneous poly(glycol monomethacrylate) gels on the healing-in of test implants. J Biomed Mater Res (1971) 0.81
Biological tolerance of poly(N-substituted acrylamides). J Biomed Mater Res (1973) 0.81
Release of macromolecules and daunomycin from hydrophilic gels containing enzymatically degradable bonds. J Biomater Sci Polym Ed (1990) 0.81
Biological tolerance of poly(N-substituted methacrylamides). J Biomed Mater Res (1971) 0.80
The chemistry, photophysics and photosensitizing properties of phthalocyanines. Ciba Found Symp (1989) 0.80
Phagocytosis of 2-hydroxyethylmethacrylate copolymer particles by different types of macrophages. Folia Biol (Praha) (1983) 0.80
Biological tolerance of ionogenic hydrophilic gels. J Biomed Mater Res (1973) 0.80
Improved synthesis and evaluation of 17-substituted aminoalkylgeldanamycin derivatives applicable to drug delivery systems. Bioorg Med Chem Lett (2001) 0.80
Enzymatic degradation and immunogenic properties of derivatized dextrans. Biomaterials (1991) 0.80
Co-expression of different types of Fc receptors on murine peritoneal macrophages. Eur J Immunol (1986) 0.80
Evaluation of protein-N-(2-hydroxypropyl)methacrylamide copolymer conjugates as targetable drug carriers. 1. Binding, pinocytic uptake and intracellular distribution of transferrin and anti-transferrin receptor antibody conjugates. Biochim Biophys Acta (1989) 0.79
HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 3. The effect of free and polymer-bound adriamycin on the expression of some genes in the OVCAR-3 human ovarian carcinoma cell line. Eur J Pharm Biopharm (2000) 0.79
Bioaffinity therapy with antibodies and drugs bound to soluble synthetic polymers. J Chromatogr (1986) 0.79
New types of synthetic infusion solutions. I. Investigation of the effect of solutions of some hydrophilic polymers on blood. J Biomed Mater Res (1973) 0.79